Doyle Andrew J, Retter Andrew, Parmar Kiran, Mayger Katarzyna, Barrett Nicholas, Camporota Luigi, Breen Karen A, Hunt Beverley J
Centre for Thrombosis and Haemostasis, St Thomas' Hospital, London, UK.
Department of Critical Care, St Thomas' Hospital, London, UK.
Perfusion. 2025 May;40(4):984-992. doi: 10.1177/02676591241267218. Epub 2024 Jul 25.
IntroductionBleeding and thrombotic events (BTE) are frequent during extracorporeal membrane oxygenation (ECMO). They occur at varying timepoints and may be affected by temporal changes in coagulation and fibrinolysis. We aimed to assess various coagulation and fibrinolytic markers over time and their relationship with BTE.MethodsA single-centre prospective study was performed in 17 patients with severe respiratory failure receiving veno-venous ECMO. Blood samples were collected before and during ECMO, and around circuit decannulation.ResultsPrior to ECMO, D-Dimer, Plasmin-Antiplasmin complexes (PAP), Plasminogen-Activator Inhibitor-1 (PAI-1) and fibrinogen were elevated. There was an increase in D-Dimer and Prothrombin Fragments 1+2 (PF1+2) (729 to 1305pmol/L, = .034) by day 1 and PAP increased by day 2 from baseline levels (median 1022 to 1797 µg/L, = .023). There was a strong positive correlation in PAP, PF1+2 and thrombin-antithrombin complexes (TAT) to D-Dimer. BTE were frequent - 18% had major extracranial haemorrhage and 24% had intracranial haemorrhage. Over time, there was a progressive elevation PAP in patients developing subsequent extracranial haemorrhage, whereas D-Dimer, PAP and PF1+2 increased after intracranial haemorrhage.ConclusionsThere were early changes in coagulation activity during ECMO by PF1+2 followed by subsequent fibrinolysis by PAP. Changes in PAP, PF1+2 and TAT were associated with major haemorrhage.
引言
在体外膜肺氧合(ECMO)期间,出血和血栓形成事件(BTE)很常见。它们发生在不同的时间点,并且可能受到凝血和纤维蛋白溶解的时间变化影响。我们旨在评估不同时间的各种凝血和纤维蛋白溶解标志物及其与BTE的关系。
方法
对17例接受静脉-静脉ECMO的严重呼吸衰竭患者进行了一项单中心前瞻性研究。在ECMO之前、期间以及撤机时采集血样。
结果
在ECMO之前,D-二聚体、纤溶酶-抗纤溶酶复合物(PAP)、纤溶酶原激活物抑制剂-1(PAI-1)和纤维蛋白原升高。第1天时D-二聚体和凝血酶原片段1+2(PF1+2)增加(从729至1305pmol/L,P = 0.034),第2天时PAP从基线水平升高(中位数从1022至1797μg/L,P = 0.023)。PAP、PF1+2和凝血酶-抗凝血酶复合物(TAT)与D-二聚体呈强正相关。BTE很常见——18%发生严重颅外出血,24%发生颅内出血。随着时间推移,发生后续颅外出血的患者PAP逐渐升高,而颅内出血后D-二聚体、PAP和PF1+2升高。
结论
ECMO期间凝血活性早期有PF1+2变化,随后有PAP介导的纤维蛋白溶解。PAP、PF1+2和TAT的变化与大出血有关。